TherapeuticsMD, Inc. (TXMD) Social Stream
THERAPEUTICSMD INC (TXMD) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering THERAPEUTICSMD INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 40 months, TXMD's average price target has gone down $2.28.
TXMD reports an average of 21.08% for its upside potential over the past 31 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
TXMD Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 21 months, TXMD's average broker recommendation rating worsened by 2.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how THERAPEUTICSMD INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 53.82% of that group.
- In the context of all US stocks, THERAPEUTICSMD INC's average analyst price target is greater than 172.57% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, THERAPEUTICSMD INC's variance in analysts' estimates is lower than -328.25% of them.
- In terms of how THERAPEUTICSMD INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 565.11% of that group.
What is the outlook for TXMD? Use POWR Ratings for clearer insight into price direction.